- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.81 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 19 x SO4: SULFATE ION(Non-functional Binders)
- 24 x ACT: ACETATE ION(Non-functional Binders)
ACT.8: 3 residues within 4Å:- Chain A: R.44, S.465, Y.487
Ligand excluded by PLIPACT.9: 2 residues within 4Å:- Chain A: R.329, L.330
Ligand excluded by PLIPACT.10: 1 residues within 4Å:- Ligands: RJR.36
Ligand excluded by PLIPACT.19: 1 residues within 4Å:- Chain A: A.1
Ligand excluded by PLIPACT.20: 4 residues within 4Å:- Chain A: D.24, S.25, F.26, R.48
Ligand excluded by PLIPACT.21: 7 residues within 4Å:- Chain A: E.235, S.237, A.238, Y.244, D.283, Q.284
- Ligands: SO4.12
Ligand excluded by PLIPACT.22: 2 residues within 4Å:- Chain A: S.45, R.47
Ligand excluded by PLIPACT.23: 2 residues within 4Å:- Chain A: K.198, G.199
Ligand excluded by PLIPACT.24: 4 residues within 4Å:- Chain A: Q.226, H.273, N.275, V.276
Ligand excluded by PLIPACT.25: 4 residues within 4Å:- Chain A: R.285, P.319, A.320, T.369
Ligand excluded by PLIPACT.26: 3 residues within 4Å:- Chain A: I.158, P.159, H.162
Ligand excluded by PLIPACT.31: 2 residues within 4Å:- Chain B: K.198, G.199
Ligand excluded by PLIPACT.32: 3 residues within 4Å:- Chain B: I.158, P.159, H.162
Ligand excluded by PLIPACT.33: 2 residues within 4Å:- Chain B: E.254, R.257
Ligand excluded by PLIPACT.34: 2 residues within 4Å:- Chain B: R.44, Y.487
Ligand excluded by PLIPACT.40: 3 residues within 4Å:- Chain B: P.289, H.290, K.293
Ligand excluded by PLIPACT.41: 5 residues within 4Å:- Chain B: Q.226, T.272, H.273, N.275, V.276
Ligand excluded by PLIPACT.42: 2 residues within 4Å:- Chain B: Q.207, R.211
Ligand excluded by PLIPACT.43: 2 residues within 4Å:- Chain B: H.274, N.275
Ligand excluded by PLIPACT.44: 2 residues within 4Å:- Chain B: R.277, H.306
Ligand excluded by PLIPACT.45: 4 residues within 4Å:- Chain B: L.67, A.438, N.442, L.444
Ligand excluded by PLIPACT.46: 6 residues within 4Å:- Chain B: Y.313, L.314, D.315, C.342, V.343
- Ligands: RJR.36
Ligand excluded by PLIPACT.47: 1 residues within 4Å:- Chain B: K.155
Ligand excluded by PLIPACT.48: 2 residues within 4Å:- Chain B: S.45, R.47
Ligand excluded by PLIP- 2 x RJR: (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[4-[3-(1-adamantylmethoxy)propyl]-1,2,3-triazol-1-yl]methyl]cyclohexane-1,2,3,5-tetrol(Covalent)
RJR.13: 17 residues within 4Å:- Chain A: D.127, F.128, W.179, N.234, E.235, L.241, F.246, Y.313, E.340, W.381, N.396, F.397, V.398
- Chain B: D.315, F.316, K.346
- Ligands: SO4.12
12 PLIP interactions:10 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:L.241, A:E.340, B:F.316, B:F.316
- Hydrogen bonds: A:D.127, A:W.179, A:N.234, A:E.235, A:E.235, A:N.396, A:F.397
- Water bridges: A:E.235
RJR.36: 20 residues within 4Å:- Chain A: F.316, L.317, F.347
- Chain B: D.127, F.128, W.179, N.234, E.235, F.246, Q.284, W.312, Y.313, F.316, E.340, C.342, W.381, N.396, V.398
- Ligands: ACT.10, ACT.46
20 PLIP interactions:3 interactions with chain A, 17 interactions with chain B- Hydrophobic interactions: A:F.316, A:L.317, A:F.347, B:Q.284, B:W.312, B:W.312, B:Y.313, B:Y.313, B:Y.313, B:Y.313, B:Y.313, B:F.316, B:E.340
- Hydrogen bonds: B:D.127, B:W.179, B:N.234, B:E.235, B:Y.313, B:N.396
- Water bridges: B:E.235
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Artola, M. et al., Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish. J.Am.Chem.Soc. (2019)
- Release Date
- 2019-03-27
- Peptides
- Glucosylceramidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
SMTL ID : 6q6l.1
Crystal structure of recombinant human beta-glucocerebrosidase in complex with adamantyl-cyclophellitol inhibitor (ME656)
Glucosylceramidase
Related Entries With Identical Sequence
1ogs.1 | 1ogs.2 | 1y7v.1 | 1y7v.2 | 1y7v.3 | 1y7v.4 | 1y7v.5 | 1y7v.6 | 2f61.1 | 2f61.2 | 2j25.1 | 2j25.2 | 2nsx.1 | 2nsx.2 | 2nsx.3 | 2nsx.4 | 2nsx.5 | 2nsx.6 | 2nsx.7 | 2nsx.8 | 2nsx.9 | 2nt0.1 | 2nt0.2 | 2nt0.3 | 2nt0.4 | 2nt1.1 | 2nt1.2 | 2nt1.3 | 2nt1.4 | 2nt1.5 more...less...3gxd.1 | 3gxf.1 | 3gxf.2 | 3gxi.1 | 3gxi.2 | 3gxi.3 | 3gxi.4 | 3gxm.1 | 3gxm.2 | 3gxm.3 | 3gxm.4 | 3rik.1 | 3rik.2 | 3ril.1 | 3ril.2 | 6moz.1 | 6moz.2 | 6q1n.1 | 6q1n.2 | 6q1p.1 | 6q1p.2 | 6q1p.3 | 6q6k.1 | 6q6n.1 | 6tjj.1 | 6tjj.2 | 6ytp.1 | 6ytp.2 | 6yut.1 | 6yut.2 | 6yv3.1 | 6yv3.2 | 6z39.1 | 8p3e.1 | 8p41.1 | 8p41.2